Open AccessReply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention
Author(s) -
Xiaoling Xu,
Mingfeng Han,
Tiantian Li,
WeiZen Sun,
Dongsheng Wang,
Binqing Fu,
Yonggang Zhou,
Xiaohu Zheng,
Yun Yang,
Xiuyong Li,
Xiaohua Zhang,
Aijun Pan,
Haiming Wei
Publication year - 2020
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2011616117
Subject(s) - tocilizumab , covid-19 , medicine , intervention (counseling) , disease , intensive care medicine , pandemic , medline , virology , outbreak , biology , infectious disease (medical specialty) , psychiatry , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom